ADRB2 and heart failure: In heart failure, the (PKA-mediated) response to enhanced β-AR stimulation is detrimental in the long term, and β-AR antagonists can decrease patients’ mortality (El-Armouche and Eschenhagen 2009; Baker 2014; Kotecha et al. 2017).